Methenolone Enanthate (Primobolan) 100 mg/mL – 10 mL

Biochem Methenolone Enanthate 100 mg/mL – 10 mL

Biochem Methenolone Enanthate 100 mg/mL – 10 mL, also known as Primobolan Depot, is a long-acting injectable anabolic-androgenic steroid containing methenolone enanthate, an ester of methenolone.

Methenolone is a synthetic derivative of dihydrotestosterone (DHT) with anabolic and androgenic properties. Methenolone preparations have historically been used in certain medical settings involving tissue wasting, recovery from debilitating illnesses, and conditions associated with protein loss, depending on the formulation and jurisdiction.

Its enanthate ester supports gradual release following intramuscular injection, resulting in a longer duration of action compared with shorter-acting methenolone formulations.

This formulation is described as an oil-based injectable solution. The specific carrier oil for the Biochem product has not been confirmed.

1. Influences Protein Synthesis

Methenolone has anabolic properties associated with androgen receptor activation and the regulation of protein metabolism in androgen-responsive tissues.

2. Influences Muscle Tissue Maintenance

Methenolone interacts with androgen receptors in skeletal muscle and may influence protein turnover and lean tissue maintenance. These pharmacological effects do not establish that nonmedical use is safe or medically appropriate.

3. Influences Nitrogen Balance

As an anabolic-androgenic steroid, methenolone may influence nitrogen metabolism, a physiological process associated with protein retention and tissue maintenance.

4. Exhibits Anabolic and Androgenic Activity

Methenolone is a DHT-derived compound that produces biological effects through androgen receptor interaction. Its anabolic and androgenic properties are associated with changes in protein metabolism and other androgen-dependent processes.

5. Has Historical Applications in Catabolic Conditions

Methenolone preparations have historically been used in certain medical settings involving tissue wasting and recovery from debilitating conditions. Such historical applications do not establish current approval for these indications in every country.

6. Provides Prolonged Hormonal Activity

The enanthate ester supports gradual release of methenolone following intramuscular administration, contributing to its extended duration of action compared with shorter-acting formulations.

7. Does Not Directly Aromatize Into Estrogen

Methenolone is derived from dihydrotestosterone and does not undergo aromatization into estrogen. This characteristic does not eliminate the possibility of endocrine disruption or other adverse effects.

Clinical outcomes vary between individuals, and performance-related benefits in healthy individuals have not been established through approved medical indications.

Methenolone enanthate is an esterified form of methenolone designed to provide prolonged release following intramuscular administration.

Step 1 – Gradual Absorption

Following intramuscular injection, methenolone enanthate is gradually released from the oil-based depot and absorbed into the bloodstream.

Step 2 – Methenolone Activation

Enzymatic hydrolysis separates the enanthate ester from the methenolone molecule, releasing biologically active methenolone.

Step 3 – Androgen Receptor Interaction

Active methenolone binds to androgen receptors in tissues including skeletal muscle, bone, and reproductive organs.

Step 4 – Anabolic Activity

Methenolone influences androgen receptor-mediated processes associated with protein metabolism, nitrogen balance, and tissue maintenance.

Step 5 – Hormonal Metabolism

Methenolone undergoes metabolic transformation and elimination through pathways associated with synthetic androgenic compounds. As a DHT-derived steroid, it does not undergo aromatization into estrogen.

Methenolone enanthate has a prolonged release profile